Ajanta Pharma, a speciality pharmaceutical formulation company, has been awarded as 'Best Managed Companies' in India by Deloitte for 2022.

The selection process for the award had a rigorous evaluation of management abilities for Strategy; Capabilities and Innovation; Governance and Financials; Culture and Commitment. It once again confirms Ajanta's agile management, resilient strategy and superior performance.

Yogesh Agrawal, Managing Director, Ajanta Pharma received the award at the Best Managed Companies programme held at Deloitte Knowledge Center in Mumbai.

"We are delighted to receive the Best Managed Companies award from Deloitte as it validates our emphasis on commitment towards excellence in people, processes, infrastructure and practices. This award is dedicated to over 7,000 motivated Ajantaites spread globally who make Ajanta an exciting and vibrant place to work," said Agrawal.

Ajanta Pharma is a speciality pharmaceutical formulation company with brandedgeneric business in India and 30 emerging markets, a generic business in the US and an institution business in Africa. Ajanta is determined to find answers to patient-need by developing differentiated 1st to market products. This smart product portfolio provides company leadership in various molecule and therapeutic segments. The company's ground presence in all the emerging markets provides it with an edge to build enduring product brands and strong equity with customers. Moreover, the company's robust supply chain ensures these medicines are available for needy patients across the globe every single day.

Ajanta's success in different markets is backed by its strong belief in R&D. Company's R&D has strong capabilities in the finished product development of different dosage forms by designing robust formulations. Ajanta has been consistently developing difficult and complex products to harness patient needs. The company's 800+ scientists embrace technology to find appropriate solutions to address the challenges faced by patients across the globe.

The company has six world-class formulations and one API manufacturing facility in India having best-in-class equipment. These facilities are run by a skilled and knowledgeable team who follows outstanding quality systems to ensure world-class quality products. Stringent authorities like the US FDA and WHO have approved the company's facilities at Paithan in Maharashtra and Dahej in Gujarat.

For the last 10 financial years, the company has posted healthy performance with its Revenue from Operations growing at 15 per cent CAGR and net profit at 23 per cent CAGR.